U.S. says two Indian nationals indicted in counterfeit Ozempic smuggling scheme
The Hindu – International
You are logged in
Loading…
You don’t have any Active Subscription.
Subscribed with another email? Logout and Login with that one.
Your active subscription(s)
Account subscription benefits alongside Premium Stories, Editorials,
Opinions and more. Unlock these with Subscription
Products you’ve access to
Additional Subscription Benefits
Account Settings
Need help with your subscription?
Weather News September 30, 2026 e-Paper
The View From India
Looking at World Affairs from the Indian perspective.
First Day First Show
News and reviews from the world of cinema and streaming.
Today's Cache
Your download of the top 5 technology stories of the day.
Science For All
The weekly newsletter from science writers takes the jargon out of science and puts the fun in!
Data Point
Decoding the headlines with facts, figures, and numbers
THEdge
At the cutting edge of education and careers
Health Matters
Ramya Kannan writes to you on getting to good health, and staying there
Gender Agenda
Stories from beyond the binary.
The Hindu On Books
Books of the week, reviews, excerpts, new titles and features.
Weather News September 30, 2026 e-Paper
Published – September 30, 2026 06:35 am IST
Image used for representational purposes only.
| Photo Credit: Getty Images/iStockphoto
A U.S. federal grand jury has indicted two Indian nationals for allegedly smuggling and selling counterfeit Ozempic, the weight-loss drug, the Department of Justice said on Tuesday (September 29, 2026). One of the defendants, Swapnadip Roy, pleaded not guilty after being extradited from Italy , while the other, Vicky Ramancha, remains at large, the department said.
Between July 2023 and April 2024, Mr. Roy and Mr. Ramancha allegedly obtained counterfeit Ozempic in China and sold it to U.S. distributors at discounted prices, it said.
A legal representative for Mr. Roy did not immediately respond to a request for comment. One for Mr. Ramancha was not immediately available.
The counterfeit medication included packaging, inserts, and labels allegedly meant to convince purchasers that they were receiving authentic Ozempic, the popular weight-loss drug that can cost hundreds of dollars per month for patients. “The scheme continued even after the FDA seized some of the counterfeit Ozempic in December 2023 and issued a public warning regarding the products,” the Justice Department said.
Mr. Roy and Mr. Ramancha were charged with smuggling and selling counterfeit drugs, conspiracy to commit smuggling and to defraud the United States. They face up to 71 years in prison if convicted.
Published – September 30, 2026 06:35 am IST
Copyright© 2026, THG PUBLISHING PVT LTD. or its affiliated companies. All rights reserved.
BACK TO TOP
Terms & conditions | Institutional Subscriber
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.
Fonte: The Hindu – International
